Deere (DE) settles right-to-repair lawsuit for $99M, granting farmers 10-year access to repair tools. Separate FTC case remains pending.
Browsing: News
Arm Holdings (ARM) dropped 3.7% after Morgan Stanley’s downgrade to Equal-Weight, citing demand softness, margin risks, and potential channel conflicts.
Oracle (ORCL) names Hilary Maxson as CFO. Wall Street analysts praise her infrastructure expertise as Oracle targets $50B in AI data center capex.
Biogen (BIIB) partners with Alloy Therapeutics on multi-target ASO platform deal. RBC Capital cuts price target to $213 while maintaining Outperform rating.
Google unveils mental health crisis features for Gemini AI and pledges $30M to global hotlines. Learn about the new one-touch support interface.
Silo Pharma (SILO) stock surged 47% after-hours following European Patent Office notice of intent to grant PTSD prevention therapy patent.
Delta Air Lines (DAL) reports Q1 earnings Wednesday. Analysts expect $14.94B revenue, $0.58 EPS. Fuel costs and summer bookings are key focus areas.
SpaceX plans historic IPO with up to 30% retail allocation, targeting $2T valuation. Roadshow begins June 8, prospectus expected late May.
Anthropic’s revenue run rate exceeds $30B, tripling in months. The AI startup secures major TPU chip deal with Google and Broadcom through 2031.
Micron (MU) stock gained 3.5% after KeyBanc’s bullish call and Samsung’s 700% profit surge highlighted booming memory chip demand driven by AI.
ASML stock declined 4.1% after U.S. lawmakers unveiled the MATCH Act, which could ban deep ultraviolet chip equipment exports to China.
Premier League’s gambling shirt sponsor ban leaves clubs facing £80M loss. Nine teams still searching for replacements worth half their previous deals.
Goldman Sachs identifies tech stocks as undervalued after historic underperformance. Sector trades at 20x P/E vs 52x during dot-com bubble, with 44% EPS growth.
Humana (HUM) stock jumped 12% after CMS announced a 2.48% Medicare Advantage rate increase for 2027, beating Wall Street’s expectations significantly.
Dutch Bros (BROS) stock declined 24% despite Q4 revenue climbing 29% and earnings beating forecasts by 70%. Analysis of fundamentals vs. market sentiment.